Journey Medical Corporation Appoints Joseph Benesch as Chief Financial Officer

May 1, 2024

https://www.globenewswire.com/news-release/2024/05/01/2873602/0/en/Journey-Medical-Corporation-Appoints-Joseph-Benesch-as-Chief-Financial-Officer.html

SCOTTSDALE, Ariz., May 01, 2024 (GLOBE NEWSWIRE) — Journey Medical Corporation (“Journey Medical” or “the Company”) (Nasdaq:DERM), a commercial-stage pharmaceutical company that primarily focuses on the selling and marketing of U.S. Food and Drug Administration (“FDA”)-approved prescription pharmaceutical products for the treatment of dermatological conditions, today announced the appointment of Joseph M. Benesch as Chief Financial Officer, effective April 26, 2024. Mr. Benesch had served as the Company’s Interim Chief Financial Officer since January 2023 and he served as the Company’s Corporate Controller prior to that since November 2021.

Read more at globenewswire.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.